UK MPs wants pharma in AIDS patent pool, while GSK makes new moves
15 July 2009
Elizabeth Sukkar
Please Login to read the full article.
15 July 2009
Elizabeth Sukkar
The prices of newer second-line antiretroviral treatments (ARTs) need to be urgently reduced to improve access to developing countries, says a new report by a group of UK members of Parliament. The report,
The Treatment Timebomb, states that by 2030 more than 50 million people...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Sanofi and DNDi to tackle nine neglected diseases
- ViiV's licensing talks with Medicines Patent Pool progressing towards a deal
- GSK first to deliver low-cost vaccine in Africa; MSF says price too high
- Broad swathe of measures to support UK life sciences draws widespread applause
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
